ArticleBlood transfusion = Trasfusione del sangue
Molecular characterization of variant D antigen expression among 56,445 blood donors in East India.
Article in Blood transfusion = Trasfusione del sangue. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Geographic boundary for the Asian-type DEL in south Asia.iScience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundTransfusion of red cells from RhD-positive donors to recipients lacking all or some epitopes of the D antigen can lead to the development of anti-D, potentially resulting in hemolytic transfusion reactions. Over 500 RHD alleles affect the qualitative or quantitative expression of the D antigen. There are huge differences in their prevalence among populations. Despite the distinct genetic diversity across multiple sub-populations in India, the prevalence of RHD alleles in the East Indian region has remained unknown. MATERIAL AND
methodsStandard hemagglutination tests were performed, along with molecular techniques to determine the nucleotide sequence of the RHD gene.
resultsOver 3 years, 56,445 blood donors were tested at the Tata Medical Center, Kolkata by serology. We found 23 samples with D-discrepant test results in immediate spin anti-D technique (0.04%), all of them were C+c+. Variant RHD alleles were identified in 15 samples (15/23, 65.2%). The Indian-type weak D (RHD*01W.150) was the most common variant (30.4%, No.=7), occurring in 1 in 8,063 blood donors in East India versus 1 in 729 blood donors in South India (p<0.001). Other identified variants included RHD*06.03.01 (No.=3), RHD*17.05 (No.=2), RHD*01.EL.37 (No.=2), and RHD*01W.96 (No.=1). The remaining 8 samples (8/23, 34.8%) carried the reference RHD allele (RHD*01.01). DISCUSSION: Our findings reveal a lower prevalence of Indian-type weak D in East India than South India, indicating region-specific genetic diversity. The high incidence of wild-type RHD allele with D-discrepancy in East India suggests a potentially novel molecular mechanism. While RHD*06.03.01 and RHD*17.05 have, the 3 others identified RHD alleles have not been associated with anti-D alloimmunization. We recommend D-negative transfusion for individuals with D-variants that have documented alloimmunization, and advocate to investigate the clinical significance of other D-variant alleles prevalent in East India, such as the Indian-type weak D.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.